Skip to main navigation
Skip to search
Skip to main content
MD Anderson Cancer Center Home
Help & FAQ
Home
Profiles
Research units
Equipment
Research output
Activities
Search by expertise, name or affiliation
Will Chinese ovarian cancer patients benefit from knowing the BRCA2 mutation status?
Guo Yan Liu, Wei Zhang
Pathology
Research output
:
Contribution to journal
›
Editorial
›
peer-review
6
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Will Chinese ovarian cancer patients benefit from knowing the BRCA2 mutation status?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Atlases
23%
BRCA1 Gene
29%
BRCA2 Gene
31%
Breast Neoplasms
28%
China
35%
Counseling
18%
Drug Therapy
12%
Genetic Counseling
24%
Genetic Testing
22%
Genome
14%
Mutation
61%
Neoplasms
14%
Ovarian Neoplasms
100%
Platinum
23%
Therapeutics
7%